Trulicity dulaglutide: Phase III data

The double-blind, international Phase III AWARD-9 trial in 300 Type II diabetics showed that once-weekly 1.5 mg Trulicity as an add-on to

Read the full 229 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE